Weimiao Li
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Endocrine and Autonomic Systems top 10%
- Circadian rhythm and melatonin
Papers in
-
- Ferroptosis and cancer prognosis 3
- Cancer-related cognitive impairment studies 3
- Lung Cancer Treatments and Mutations 3
-
- Epigenetics and DNA Methylation 5
- RNA modifications and cancer 4
- Ubiquitin and proteasome pathways 2
- Co-authors
- Xiaofei Li (18 shared papers)Xiaolong Yan (12 shared papers)Zhipei Zhang (11 shared papers)Shouyin Di (6 shared papers)Zhiqiang Ma (5 shared papers)Liqun Xu (4 shared papers)Guoxu Zheng (5 shared papers)Jinbo Zhao (9 shared papers)
- Journals
- Knowledge-Based Systems (2 papers)Biochemical and Biophysical Research Communications (2 papers)Breast Cancer (2 papers)Pain Research and Management (1 paper)BioMed Research International (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Weimiao Li
45 papers receiving 833 citations
Peers
Comparison fields: 5 of 112
- Cancer Research 159
- Endocrine and Autonomic Systems 56
- Biological Psychiatry 19
- Geriatrics and Gerontology 24
- Pulmonary and Respiratory Medicine 161
Countries citing papers authored by Weimiao Li
This map shows the geographic impact of Weimiao Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weimiao Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weimiao Li more than expected).
Fields of papers citing papers by Weimiao Li
This network shows the impact of papers produced by Weimiao Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weimiao Li. The network helps show where Weimiao Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Weimiao Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 87 | |
| 2 | 2022 | 71 | |
| 3 | 2019 | 58 | |
| 4 | 2019 | 55 | |
| 5 | 2019 | 55 | |
| 6 | 2020 | 45 | |
| 7 | 2020 | 44 | |
| 8 | 2017 | 38 | |
| 9 | 2019 | 36 | |
| 10 | 2016 | 27 | |
| 11 | 2015 | 27 | |
| 12 | 2018 | 26 | |
| 13 | Inhibiting CREPT reduces the proliferation and migration of non-small cell lung cancer cells by down-regulating cell cycle related protein. | 2016 | 26 |
| 14 | 2014 | 25 | |
| 15 | 2020 | 24 | |
| 16 | 2015 | 19 | |
| 17 | 2019 | 19 | |
| 18 | 2013 | 17 | |
| 19 | 2020 | 14 | |
| 20 | 2015 | 12 |
About Weimiao Li
Weimiao Li is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Cancer Research and Immunology, having authored 47 papers that have together received 841 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (5 papers), Tryptophan and brain disorders (4 papers), RNA modifications and cancer (4 papers), Time Series Analysis and Forecasting (3 papers), Ferroptosis and cancer prognosis (3 papers), Cancer-related cognitive impairment studies (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Cancer Research (159 citations), Endocrine and Autonomic Systems (56 citations), Biological Psychiatry (19 citations), Geriatrics and Gerontology (24 citations) and Pulmonary and Respiratory Medicine (161 citations). Weimiao Li has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Xiaofei Li, Xiaolong Yan, Zhipei Zhang, Shouyin Di, Zhiqiang Ma, Liqun Xu, Guoxu Zheng, Jinbo Zhao, Zhangyan Guo and Angang Yang. Their work appears in journals such as Knowledge-Based Systems, Biochemical and Biophysical Research Communications, Breast Cancer, Pain Research and Management and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.